Company Number: SC719182

Analysis Date: 2025-07-20 13:32 UTC

1. Credit Opinion: APPROVE
   50187 LIMITED demonstrates strong liquidity and a solid equity base relative to its size, indicating a good ability to meet short-term obligations. The company is active, with no overdue filings or signs of financial distress, and the sole director appears to maintain proper stewardship. Given its micro-entity status and the industry of specialist medical practice, credit risk is low under current conditions.

2. Financial Strength:
   The company’s balance sheet shows steady growth over two years, with total assets less current liabilities increasing from £18,778 in 2023 to £69,220 in 2024. Fixed assets remain minimal, appropriate for a service-based medical practice. Net current assets have grown significantly from £18,553 to £68,243, reflecting improved working capital management and an increase in current assets, mainly cash or receivables. Shareholders’ funds mirror this growth, indicating retained earnings or capital injections supporting financial stability.

3. Cash Flow Assessment:
   Current assets of £87,331 against current liabilities of £19,088 provide a healthy current ratio of about 4.6x, signaling strong liquidity and an ability to cover short-term debts multiple times over. The absence of employees suggests low operating overhead, reducing cash burn risk. The company’s working capital position is robust, which bodes well for ongoing operational funding and servicing any credit facilities.

4. Monitoring Points:

• Continued growth in net current assets and maintenance of liquidity ratios above 2x.
• Confirmation that no new debts are taken on that could stress the balance sheet.
• Watch for any changes in director or ownership structure that may impact governance.
• Monitor the operating environment for specialist medical services for potential regulatory or market changes.